Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decrease in venous irritation by adjusting the concentration of injected bendamustine.
Watanabe H, Ikesue H, Tsujikawa T, Nagata K, Uchida M, Suetsugu K, Egashira N, Muta T, Kato K, Takenaka K, Ohga S, Matsushima T, Shiratsuchi M, Miyamoto T, Teshima T, Akashi K, Oishi R. Watanabe H, et al. Among authors: suetsugu k. Biol Pharm Bull. 2013;36(4):574-8. doi: 10.1248/bpb.b12-00901. Epub 2013 Feb 8. Biol Pharm Bull. 2013. PMID: 23392075 Free article. Clinical Trial.
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation.
Uchida M, Ikesue H, Miyamoto T, Kato K, Suetsugu K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Muta T, Iwasaki H, Teshima T, Shiratsuchi M, Egashira N, Akashi K, Oishi R. Uchida M, et al. Among authors: suetsugu k. Biol Pharm Bull. 2013;36(5):819-24. doi: 10.1248/bpb.b12-01012. Biol Pharm Bull. 2013. PMID: 23649338 Free article.
Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation.
Uchida M, Kato K, Ikesue H, Ichinose K, Hiraiwa H, Sakurai A, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Shiratsuchi M, Suetsugu K, Nagata K, Egashira N, Akashi K, Oishi R. Uchida M, et al. Among authors: suetsugu k. Pharmacotherapy. 2013 Sep;33(9):893-901. doi: 10.1002/phar.1294. Epub 2013 May 26. Pharmacotherapy. 2013. PMID: 23712662 Free PMC article.
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Suetsugu K, Ikesue H, Miyamoto T, Shiratsuchi M, Yamamoto-Taguchi N, Tsuchiya Y, Matsukawa K, Uchida M, Watanabe H, Akashi K, Masuda S. Suetsugu K, et al. Int J Hematol. 2017 Mar;105(3):361-368. doi: 10.1007/s12185-016-2135-7. Epub 2016 Nov 7. Int J Hematol. 2017. PMID: 27822915
Risk Factors for Gemcitabine-Induced Vascular Pain in Patients With Pancreatic Cancer.
Ishida S, Makihara Y, Watanabe H, Nakashima T, Nagata K, Suetsugu K, Tsuji T, Hata K, Ikeda M, Ikebe M, Minami H, Watanabe H, Nakata K, Nakamura M, Egashira N, Ieiri I. Ishida S, et al. Among authors: suetsugu k. Ann Pharmacother. 2021 Jun;55(6):738-744. doi: 10.1177/1060028020969354. Epub 2020 Oct 23. Ann Pharmacother. 2021. PMID: 33094647
Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events.
Matsukane R, Watanabe H, Minami H, Hata K, Suetsugu K, Tsuji T, Masuda S, Okamoto I, Nakagawa T, Ito T, Eto M, Mori M, Nakanishi Y, Egashira N. Matsukane R, et al. Among authors: suetsugu k. Sci Rep. 2021 Jan 14;11(1):1324. doi: 10.1038/s41598-020-79397-6. Sci Rep. 2021. PMID: 33446685 Free PMC article.
134 results